Paul J Pockros Selected Research

Paul J Pockros Research Topics

Disease

36	Infections 06/2022 - 04/2002
33	Chronic Hepatitis C 01/2019 - 04/2002
25	Fibrosis (Cirrhosis) 01/2021 - 04/2002
9	Hepatitis C 11/2018 - 04/2002
7	Liver Diseases (Liver Disease) 01/2023 - 08/2002
6	Anemia 06/2016 - 05/2004
4	Pruritus (Itching) 01/2023 - 08/2016
4	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 01/2020 - 08/2016
3	Inflammation (Inflammations) 01/2021 - 06/2006
3	Virus Diseases (Viral Diseases) 06/2014 - 06/2003
2	Sclerosing Cholangitis 01/2023 - 01/2021
2	Chronic Hepatitis B 06/2022 - 01/2021
2	Acute Liver Failure (Fulminant Hepatic Failure) 01/2021 - 09/2011
2	Thrombocytopenia (Thrombopenia) 10/2020 - 08/2002
2	Kidney Diseases (Kidney Disease) 02/2019 - 02/2019
2	Chronic Renal Insufficiency 02/2019 - 06/2016
2	Liver Cirrhosis (Hepatic Cirrhosis) 03/2016 - 03/2003
2	Lymphopenia (Lymphocytopenia) 01/2012 - 08/2007
2	Neutropenia 01/2012 - 08/2008
2	Headache (Headaches) 08/2007 - 05/2004
1	Cholestasis 01/2023
1	Hepatitis 06/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Hemorrhage 10/2020
1	Non-alcoholic Fatty Liver Disease 11/2019
1	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 03/2019
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2016
1	Reinjuries 01/2016
1	Cardiotoxicity 08/2015
1	Cardiomyopathies (Cardiomyopathy) 08/2015
1	Persistent Infection 11/2014
1	Exanthema (Rash) 12/2013
1	Chemical and Drug Induced Liver Injury 11/2013

Drug/Important Bio-Agent (IBA)

26	Ribavirin (Virazole)FDA LinkGeneric 02/2019 - 03/2004
16	InterferonsIBA 08/2016 - 10/2002
11	Antiviral Agents (Antivirals)IBA 02/2019 - 04/2002
7	RNA (Ribonucleic Acid)IBA 01/2018 - 10/2002
6	SofosbuvirIBA 11/2018 - 04/2014
5	peginterferon alfa-2a (Pegasys)FDA Link 01/2012 - 10/2002
4	obeticholic acidIBA 01/2020 - 08/2016
4	ombitasvirIBA 02/2019 - 06/2016
4	Ritonavir (Norvir)FDA Link 02/2019 - 06/2016
4	paritaprevirIBA 02/2019 - 06/2016
4	dasabuvirIBA 02/2019 - 06/2016
4	ledipasvirIBA 11/2018 - 04/2014
4	BilirubinIBA 11/2018 - 04/2007
4	Protease Inhibitors (Protease Inhibitor)IBA 08/2016 - 12/2013
3	Bile Acids and Salts (Bile Acids)IBA 01/2023 - 03/2019
3	NucleotidesIBA 06/2022 - 05/2014
3	NucleosidesIBA 06/2022 - 02/2013
3	AlbuminsIBA 11/2018 - 04/2007
3	daclatasvirIBA 06/2015 - 04/2015
3	SimeprevirIBA 11/2014 - 12/2013
3	telaprevirIBA 06/2014 - 04/2013
3	Interferon-alpha (Interferon Alfa)IBA 08/2007 - 05/2004
2	maralixibatIBA 01/2023 - 03/2019
2	nasIBA 06/2022 - 01/2021
2	Alkaline PhosphataseIBA 01/2021 - 08/2016
2	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 03/2019 - 08/2016
2	elbasvirIBA 01/2018 - 07/2015
2	grazoprevirIBA 01/2018 - 07/2015
2	sofosbuvir drug combination ledipasvirIBA 12/2016 - 05/2014
2	deleobuvirIBA 08/2016 - 02/2013
2	N- (3- amino- 1- (cyclobutylmethyl)- 2,3- dioxopropyl)- 3- (2- ((((1,1- dimethylethyl)amino)carbonyl)amino)- 3,3- dimethyl- 1- oxobutyl)- 6,6- dimethyl- 3- azabicyclo(3.1.0)hexan- 2- carboxamideIBA 12/2013 - 04/2013
2	AntibodiesIBA 07/2012 - 08/2002
2	balapiravirIBA 01/2012 - 08/2008
2	Alanine Transaminase (SGPT)IBA 10/2010 - 02/2006
2	ProdrugsIBA 09/2009 - 08/2009
2	taribavirin (viramidine)IBA 09/2009 - 08/2009
2	Hyaluronic Acid (Hyaluronan)IBA 04/2007 - 03/2003
2	Epoetin Alfa (Epogen)FDA Link 12/2004 - 05/2004
1	bile acid binding proteinsIBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	Hepatitis B e AntigensIBA 06/2022
1	CC ChemokinesIBA 01/2021
1	cenicrivirocIBA 01/2021
1	Thrombopoietin ReceptorsIBA 10/2020
1	CollagenIBA 01/2020
1	Atorvastatin (Lipitor)FDA Link 11/2019
1	Lipoproteins (Lipoprotein)IBA 11/2019
1	sodium-bile acid cotransporterIBA 03/2019
1	Drug CombinationsIBA 09/2017
1	Proton Pump InhibitorsIBA 12/2016
1	faldaprevirIBA 08/2016
1	Erythropoietin FDA Link 06/2016
1	MicroRNAs (MicroRNA)IBA 03/2016
1	Ethiodized Oil (Ethiodol)FDA Link 01/2016
1	N 30IBA 06/2015
1	Proteins (Proteins, Gene)FDA Link 05/2015
1	asunaprevirIBA 05/2015
1	8- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA 05/2015
1	TabletsIBA 04/2014

Therapy/Procedure

33	Therapeutics 06/2022 - 04/2002
3	Drug Tapering 09/2009 - 05/2004
2	Liver Transplantation 01/2021 - 08/2002
2	Aftercare (After-Treatment) 12/2016 - 03/2003
2	Contraindications 08/2009 - 07/2003
1	Platelet Transfusion (Blood Platelet Transfusions) 10/2020
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Renal Dialysis (Hemodialysis) 06/2016